Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to $451000.0.

  • Barinthus Biotherapeutics' Cash from Investing Activities rose 49561.4% to $451000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136000.0, marking a year-over-year increase of 12950.11%. This contributed to the annual value of -$892000.0 for FY2024, which is 8352.12% up from last year.
  • Latest data reveals that Barinthus Biotherapeutics reported Cash from Investing Activities of $451000.0 as of Q3 2025, which was up 49561.4% from -$32000.0 recorded in Q2 2025.
  • In the past 5 years, Barinthus Biotherapeutics' Cash from Investing Activities ranged from a high of $451000.0 in Q3 2025 and a low of -$12.2 million during Q4 2021
  • Over the past 5 years, Barinthus Biotherapeutics' median Cash from Investing Activities value was -$278000.0 (recorded in 2024), while the average stood at -$1.3 million.
  • Per our database at Business Quant, Barinthus Biotherapeutics' Cash from Investing Activities tumbled by 615128.21% in 2021 and then skyrocketed by 49561.4% in 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' Cash from Investing Activities (Quarter) stood at -$12.2 million in 2021, then skyrocketed by 95.19% to -$586000.0 in 2022, then surged by 126.11% to $153000.0 in 2023, then crashed by 281.7% to -$278000.0 in 2024, then soared by 262.23% to $451000.0 in 2025.
  • Its Cash from Investing Activities was $451000.0 in Q3 2025, compared to -$32000.0 in Q2 2025 and -$5000.0 in Q1 2025.